Survival with docetaxel plus capecitabine comparing with vinorelbine plus capecitabine followed by capecitabine maintenance treatment as first-line therapy in patients with advanced breast cancer: A phase III randomized clinical trial

被引：0
|
作者：
Xu, Binghe
Wang, Jiayu
Li, Qing
Zhang, Pin
Yuan, Peng
Ma, Fei
Cai, Ruigang
Fan, Ying
Luo, Yang
Li, Qiao
机构：
[1] Chinese Acad Med Sci, Canc Hosp, Beijing 100730, Peoples R China
[2] Chinese Acad Med Sci, Canc Hosp & Inst, Beijing 100730, Peoples R China
[3] Peking Union Med Coll, Beijing 100021, Peoples R China
[4] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Med Oncol, Beijing 100730, Peoples R China
[5] Chinese Acad Med Sci, Canc Hosp, Dept Med Oncol, Beijing 100730, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.1049
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1049
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Results of a Phase II Trial of Cetuximab plus Capecitabine/Irinotecan as First-Line Therapy for Patients with Advanced and/or Metastatic Colorectal Cancer
    Cartwright, Thomas
    Kuefler, Paul
    Cohn, Allen
    Hyman, William
    Berger, Maury
    Richards, Donald
    Vukelja, Svetislava
    Nugent, John E.
    Ruxer, Robert L., Jr.
    Boehm, Kristi A.
    Asmar, Lina
    CLINICAL COLORECTAL CANCER, 2008, 7 (06) : 390 - 397
  • [42] A multi-center, open-label, randomized phase III trial of first-line chemotherapy with capecitabine monotherapy versus capecitabine plus oxaliplatin in elderly patients with advanced gastric cancer
    Hwang, In Gyu
    Ji, Yin Ho
    Kang, Jung Hun
    Lee, Hyo Rak
    Lee, Hui-Young
    Chi, Kyong-Choun
    Park, Suk Won
    Lee, Su Jin
    Kim, Seung Tae
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Park, Young Suk
    Lim, Ho Yeong
    Kang, Won Ki
    JOURNAL OF GERIATRIC ONCOLOGY, 2017, 8 (03) : 170 - 175
  • [43] Randomized Phase III Trial of Ixabepilone Plus Capecitabine Versus Capecitabine in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane
    Sparano, Joseph A.
    Vrdoljak, Eduard
    Rixe, Oliver
    Xu, Binghe
    Manikhas, Alexey
    Medina, Carlos
    Ventilari Da Costa, Susanne Crocamo
    Ro, Jungsil
    Rubio, Gonzalo
    Rondinon, Monica
    Perez Manga, Gumersindo
    Peck, Ronald
    Poulart, Valerie
    Conte, Pierfranco
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (20) : 3256 - 3263
  • [44] A phase I trial of oral metronomic vinorelbine plus capecitabine in patients with metastatic breast cancer
    Saridaki, Zacharenia
    Malamos, Nikolaos
    Kourakos, Panagiotis
    Polyzos, Aristides
    Ardavanis, Alexandros
    Androulakis, Nikolaos
    Kalbakis, Kostas
    Vamvakas, Lambros
    Georgoulias, Vassilis
    Mavroudis, Dimitris
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (01) : 35 - 42
  • [45] A phase I trial of oral metronomic vinorelbine plus capecitabine in patients with metastatic breast cancer
    Zacharenia Saridaki
    Nikolaos Malamos
    Panagiotis Kourakos
    Aristides Polyzos
    Alexandros Ardavanis
    Nikolaos Androulakis
    Kostas Kalbakis
    Lambros Vamvakas
    Vassilis Georgoulias
    Dimitris Mavroudis
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 35 - 42
  • [46] Safety and efficacy of the combination of trastuzumab plus capecitabine and docetaxel as first-line therapy for metastatic breast cancer: phase II results
    Michalaki, V.
    Gennatas, S.
    Gennatas, C.
    EJC SUPPLEMENTS, 2009, 7 (02): : 276 - 276
  • [47] A randomized phase 2 trial of first-line docetaxel, carboplatin, capecitabine (CTX) and epirubicin, oxaliplatin, capecitabine (EOX) in advanced esophagogastric adenocarcinoma
    Petersen, Peter C.
    Petersen, Lone N.
    Vogelius, Ivan
    Bjerregaard, Jon K.
    Baeksgaard, Lene
    ACTA ONCOLOGICA, 2021, 60 (07) : 948 - 953
  • [48] A PHASE III RANDOMIZED, DOUBLE-BLIND, TRIAL COMPARING SORAFENIB PLUS CAPECITABINE VERSUS PLACEBO PLUS CAPECITABINE IN THE TREATMENT OF LOCALLY ADVANCED OR METASTATIC HER2-NEGATIVE BREAST CANCER (RESILIENCE)
    Baselga, J.
    Zamagni, C.
    Gomez, P.
    Bermejo, B.
    Nagai, S.
    Melichar, B.
    Chan, A.
    Mangel, L.
    Bergh, J.
    Costa, F. P.
    Gomez, H. L.
    Gradishar, W.
    Hudis, C. A.
    Rapoport, B.
    Roche, H.
    Maeda, P.
    Huang, L.
    Zhang, J.
    Schwartzberg, L.
    ANNALS OF ONCOLOGY, 2014, 25
  • [49] Capecitabine maintenance therapy following docetaxel/capecitabine combination treatment. in patients with metastatic breast cancer
    Surmeli, Zeki Gokhan
    Varol, Umut
    Cakar, Burcu
    Degirmenci, Mustafa
    Arslan, Cagatay
    Piskin, Gonul Demir
    Zengel, Baha
    Karaca, Burcak
    Sanli, Ulus Ali
    Uslu, Ruchan
    ONCOLOGY LETTERS, 2015, 10 (04) : 2598 - 2602
  • [50] Randomized multicenter phase II trial of two different schedules of capecitabine plus oxaliplatin as first-line treatment in advanced colorectal cancer
    Scheithauer, W
    Kornek, GV
    Raderer, M
    Schüll, B
    Schmid, K
    Kovats, E
    Schneeweiss, B
    Lang, F
    Lenauer, A
    Depisch, D
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (07) : 1307 - 1312
12345